ADVERSE O
REACTIONS O
( O
Listed O
alphabetically O
, O
under O
each O
subsection O
) O
The O
following O
adverse O
reactions O
have O
been O
reported O
with O
dexamethasone O
or O
other O
corticosteroids O
: O
Allergic O
Reactions O
Anaphylactoid B-OSE_Labeled_AE
reaction I-OSE_Labeled_AE
, O
anaphylaxis B-OSE_Labeled_AE
, O
angioedema B-OSE_Labeled_AE
. O

Cardiovascular O
Bradycardia B-OSE_Labeled_AE
, O
cardiac B-OSE_Labeled_AE
arrest I-OSE_Labeled_AE
, O
cardiac B-OSE_Labeled_AE
arrhythmias I-OSE_Labeled_AE
, O
cardiac B-OSE_Labeled_AE
enlargement I-OSE_Labeled_AE
, O
circulatory B-OSE_Labeled_AE
collapse I-OSE_Labeled_AE
, O
congestive B-OSE_Labeled_AE
heart I-OSE_Labeled_AE
failure I-OSE_Labeled_AE
, O
fat B-OSE_Labeled_AE
embolism I-OSE_Labeled_AE
, O
hypertension B-OSE_Labeled_AE
, O
hypertrophic B-OSE_Labeled_AE
cardiomyopathy I-OSE_Labeled_AE
in I-OSE_Labeled_AE
premature I-OSE_Labeled_AE
infants I-OSE_Labeled_AE
, O
myocardial B-OSE_Labeled_AE
rupture I-OSE_Labeled_AE
following O
recent O
myocardial B-Not_AE_Candidate
infarction I-Not_AE_Candidate
( O
see O
WARNINGS O
: O
Cardio-Renal O
) O
, O
edema B-OSE_Labeled_AE
, O
pulmonary B-OSE_Labeled_AE
edema I-OSE_Labeled_AE
, O
syncope B-OSE_Labeled_AE
, O
tachycardia B-OSE_Labeled_AE
, O
thromboembolism B-OSE_Labeled_AE
, O
thrombophlebitis B-OSE_Labeled_AE
, O
vasculitis B-OSE_Labeled_AE
. O

Dermatologic O
Acne B-OSE_Labeled_AE
, O
allergic B-OSE_Labeled_AE
dermatitis I-OSE_Labeled_AE
, O
dry B-OSE_Labeled_AE
scaly O
skin I-OSE_Labeled_AE
, O
ecchymoses B-OSE_Labeled_AE
and O
petechiae B-OSE_Labeled_AE
, O
erythema B-OSE_Labeled_AE
, O
impaired B-OSE_Labeled_AE
wound I-OSE_Labeled_AE
healing I-OSE_Labeled_AE
, O
increased B-OSE_Labeled_AE
sweating I-OSE_Labeled_AE
, O
rash B-OSE_Labeled_AE
, O
striae B-OSE_Labeled_AE
, O
suppression B-OSE_Labeled_AE
of I-OSE_Labeled_AE
reactions I-OSE_Labeled_AE
to I-OSE_Labeled_AE
skin I-OSE_Labeled_AE
tests I-OSE_Labeled_AE
, O
thin B-OSE_Labeled_AE
fragile I-OSE_Labeled_AE
skin I-OSE_Labeled_AE
, O
thinning B-OSE_Labeled_AE
scalp I-OSE_Labeled_AE
hair I-OSE_Labeled_AE
, O
urticaria B-OSE_Labeled_AE
. O

Endocrine O
Decreased B-OSE_Labeled_AE
carbohydrate I-OSE_Labeled_AE
and O
glucose O
tolerance I-OSE_Labeled_AE
, O
development O
of O
cushingoid B-OSE_Labeled_AE
state I-OSE_Labeled_AE
, O
hyperglycemia B-OSE_Labeled_AE
, O
glycosuria B-OSE_Labeled_AE
, O
hirsutism B-OSE_Labeled_AE
, O
hypertrichosis B-OSE_Labeled_AE
, O
increased B-OSE_Labeled_AE
requirements I-OSE_Labeled_AE
for I-OSE_Labeled_AE
insulin I-OSE_Labeled_AE
or O
oral O
hypoglycemic O
agents O
in I-OSE_Labeled_AE
diabetes I-OSE_Labeled_AE
, O
manifestations O
of O
latent B-OSE_Labeled_AE
diabetes I-OSE_Labeled_AE
mellitus I-OSE_Labeled_AE
, O
menstrual B-OSE_Labeled_AE
irregularities I-OSE_Labeled_AE
, O
secondary B-OSE_Labeled_AE
adrenocortical I-OSE_Labeled_AE
and O
pituitary O
unresponsiveness I-OSE_Labeled_AE
( O
particularly O
in O
times O
of O
stress B-Not_AE_Candidate
, O
as O
in O
trauma O
, O
surgery O
, O
or O
illness B-Not_AE_Candidate
) O
, O
suppression B-OSE_Labeled_AE
of I-OSE_Labeled_AE
growth I-OSE_Labeled_AE
in I-OSE_Labeled_AE
pediatric I-OSE_Labeled_AE
patients I-OSE_Labeled_AE
. O

Fluid O
and O
Electrolyte O
Disturbances O
Congestive B-OSE_Labeled_AE
heart I-OSE_Labeled_AE
failure I-OSE_Labeled_AE
in O
susceptible O
patients O
, O
fluid B-OSE_Labeled_AE
retention I-OSE_Labeled_AE
, O
hypokalemic B-OSE_Labeled_AE
alkalosis I-OSE_Labeled_AE
, O
potassium B-OSE_Labeled_AE
loss I-OSE_Labeled_AE
, O
sodium B-OSE_Labeled_AE
retention I-OSE_Labeled_AE
. O

Gastrointestinal O
Abdominal B-OSE_Labeled_AE
distention I-OSE_Labeled_AE
, O
elevation B-OSE_Labeled_AE
in I-OSE_Labeled_AE
serum I-OSE_Labeled_AE
liver I-OSE_Labeled_AE
enzyme I-OSE_Labeled_AE
levels I-OSE_Labeled_AE
( O
usually O
reversible O
upon O
discontinuation O
) O
, O
hepatomegaly B-OSE_Labeled_AE
, O
increased B-OSE_Labeled_AE
appetite I-OSE_Labeled_AE
, O
nausea B-OSE_Labeled_AE
, O
pancreatitis B-OSE_Labeled_AE
, O
peptic B-OSE_Labeled_AE
ulcer I-OSE_Labeled_AE
with O
possible O
perforation O
and O
hemorrhage O
, O
perforation B-OSE_Labeled_AE
of I-OSE_Labeled_AE
the I-OSE_Labeled_AE
small I-OSE_Labeled_AE
and O
large O
intestine I-OSE_Labeled_AE
( O
particularly O
in O
patients O
with O
inflammatory B-Not_AE_Candidate
bowel I-Not_AE_Candidate
disease I-Not_AE_Candidate
) O
, O
ulcerative B-OSE_Labeled_AE
esophagitis I-OSE_Labeled_AE
. O

Metabolic O
Negative B-NonOSE_AE
nitrogen I-NonOSE_AE
balance I-NonOSE_AE
due O
to O
protein B-OSE_Labeled_AE
catabolism I-OSE_Labeled_AE
. O

Musculoskeletal O
Aseptic B-OSE_Labeled_AE
necrosis I-OSE_Labeled_AE
of I-OSE_Labeled_AE
femoral I-OSE_Labeled_AE
and O
humeral O
heads I-OSE_Labeled_AE
, O
loss B-OSE_Labeled_AE
of I-OSE_Labeled_AE
muscle I-OSE_Labeled_AE
mass I-OSE_Labeled_AE
, O
muscle B-OSE_Labeled_AE
weakness I-OSE_Labeled_AE
, O
osteoporosis B-OSE_Labeled_AE
, O
pathologic B-OSE_Labeled_AE
fracture I-OSE_Labeled_AE
of I-OSE_Labeled_AE
long I-OSE_Labeled_AE
bones I-OSE_Labeled_AE
, O
steroid B-OSE_Labeled_AE
myopathy I-OSE_Labeled_AE
, O
tendon B-OSE_Labeled_AE
rupture I-OSE_Labeled_AE
, O
vertebral B-OSE_Labeled_AE
compression I-OSE_Labeled_AE
fractures I-OSE_Labeled_AE
. O

Neurological/Psychiatric O
Convulsions B-OSE_Labeled_AE
, O
depression B-OSE_Labeled_AE
, O
emotional B-OSE_Labeled_AE
instability I-OSE_Labeled_AE
, O
euphoria B-OSE_Labeled_AE
, O
headache B-OSE_Labeled_AE
, O
increased B-OSE_Labeled_AE
intracranial I-OSE_Labeled_AE
pressure I-OSE_Labeled_AE
with O
papilledema B-OSE_Labeled_AE
( O
pseudotumor B-OSE_Labeled_AE
cerebri I-OSE_Labeled_AE
) O
usually O
following O
discontinuation O
of O
treatment O
, O
insomnia B-OSE_Labeled_AE
, O
mood B-OSE_Labeled_AE
swings I-OSE_Labeled_AE
, O
neuritis B-OSE_Labeled_AE
, O
neuropathy B-OSE_Labeled_AE
, O
paresthesia B-OSE_Labeled_AE
, O
personality B-OSE_Labeled_AE
changes I-OSE_Labeled_AE
, O
psychic B-OSE_Labeled_AE
disorders I-OSE_Labeled_AE
, O
vertigo B-OSE_Labeled_AE
. O

Ophthalmic O
Exophthalmos B-OSE_Labeled_AE
, O
glaucoma B-OSE_Labeled_AE
, O
increased B-OSE_Labeled_AE
intraocular I-OSE_Labeled_AE
pressure I-OSE_Labeled_AE
, O
posterior B-OSE_Labeled_AE
subcapsular I-OSE_Labeled_AE
cataracts I-OSE_Labeled_AE
. O

Other O
Abnormal B-OSE_Labeled_AE
fat I-OSE_Labeled_AE
deposits I-OSE_Labeled_AE
, O
decreased B-OSE_Labeled_AE
resistance I-OSE_Labeled_AE
to I-OSE_Labeled_AE
infection I-OSE_Labeled_AE
, O
hiccups B-OSE_Labeled_AE
, O
increased B-OSE_Labeled_AE
or O
decreased O
motility I-OSE_Labeled_AE
and O
number O
of I-OSE_Labeled_AE
spermatozoa I-OSE_Labeled_AE
, O
malaise B-OSE_Labeled_AE
, O
moon B-OSE_Labeled_AE
face I-OSE_Labeled_AE
, O
weight B-OSE_Labeled_AE
gain I-OSE_Labeled_AE
. O

